Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q2 FY23 Earnings Presentation
26 slides from Apollo Hospitals Enterprise's earnings presentation, Nov 11, 2022
Slide 1: Regulation 30 disclosure letter to stock exchanges
i APOLLO HOSPITALS ENTERPRISE LIMITED Apollo CIN : L85110TN1979PLC008035 Touc sige Lives 11 November 2022 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, ‘G’ Block Mumbai - 400 00
Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q2 FY23
APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q2 FY23
Slide 3: Key Highlights
Key Highlights Highlights Financials Healthcare Services Diagnostics & Retail Digital Health Annexure Health & Pharmacy Distribution 2
Slide 4: Highlights
HIGHLIGHTS 3
Slide 5: Highlights Q2FY23
Highlights Q2FY23 Healthcare Revenue EBITDA Services 44 Owned 9,425 68% ` 22,645 Mio ` 5,713 Mio INR 50,353 / 143,387 (Hospitals) + Beds Occupancy day In-patients Rev 53% 25.2% 5 Managed ARPOB1 Share Margin Hospitals ` 3,183 Mio ` 377 Mio Diagnostics & Rev 7% 11.8% Share Retail Health 22 ~1,500 Marg
Slide 6: Highlights Q2FY23
Highlights Q2FY23 o Consolidated Revenues at `42,511 Mio growth of 22% yoy excluding vaccination revenue in Q2FY22. o Consolidated EBITDA before 247 operating cost of `7,398 Mio Financial o 247 costs at `1,744 Mio including Non Cash ESOP Charge of `220 Mio. Performance o Consolidated PAT of `2,197 M
Slide 7: Financials: Consolidated
Financials Consolidated 6
Slide 8: Consolidated Financials Q2 FY23
Consolidated Financials Q2 FY23 Digital Health Healthcare Diagnostics & ` Mio & Pharmacy Consol Services Retail Health Distribution Total Revenues 22,645 3,183 16,683 42,511 EBITDA (Post Ind AS 116) (Pre 24|7 Cost) 5,712 377 1,308 7,398 Gross Debt 25,599 margin (%) 25.2% 11.9% 7.8% 17.4% 24/7 Operat
Slide 9: Consolidated Financials H1 FY23
Consolidated Financials H1 FY23 (` mio) Digital Health & Healthcare Diagnostics & ` Mio Pharmacy Consol Services Retail Health Distribution Total Revenues 42,879 6,113 31,475 80,467 EBITDA (Post Ind AS 116) (Pre 24|7 Cost) 10,556 672 2,490 13,717 margin (%) 24.6% 11.0% 7.9% 17.0% 24/7 Operating Cost
Slide 10: Healthcare Services: Hospitals
Healthcare Services Hospitals Consolidated 9
Slide 11: Consolidated Healthcare Services Performance Q2FY23
Consolidated Healthcare Services Performance Q2FY23 Healthcare Healthcare Healthcare Serv Volume growth of 19% from 120,105 in Q2FY22 to ` Mio Serv Group Serv Group Group 143,387 in Q2FY23 (Mature) (New & Others) No of Hospitals 29 15 44 Operating beds 5449 2423 7872 Covid medical discharges had hig
Slide 12: Consolidated Healthcare Services Performance H1FY23
Consolidated Healthcare Services Performance H1FY23 Healthcare Healthcare Healthcare Serv ` Mio Serv Group Serv Group Revenue grew by 12%YoY excluding covid Group (Mature) (New & Others) vaccination No of Hospitals 29 15 44 Operating beds 5449 2423 7872 Occupancy 66% 59% 64% Revenue 30,386 12,493 42
Slide 13: Region wise Operational Parameters
Region wise Operational Parameters Tamilnadu Region AP, Telengana Region Total (6) (2) (Chennai & others) (1) (Hyderabad & others) Particulars H1 FY 22 H1 FY 23 yoy (%) H1 FY 22 H1 FY 23 yoy (%) H1 FY 22 H1 FY 23 yoy (%) H1 FY23 ARPOB in Metro cities at No. of Operating beds 7,647 7,872 2,147 2,151
Slide 14: Diagnostics & Retail Health
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd 13
Slide 15: Executive Summary
Executive Summary ➢ Network grew by 19% in H1 FY23 from 468 touchpoints in FY22 to 557 touchpoints in H1 FY23 Primary ➢ Health checks and Consultations volumes grew by 20% and 73% respectively Care ➢ Focus on expanding network to take care closer to communities ➢ Diagnostics business added 260+ coll
Slide 16: Financial Performance Q2FY23
Financial Performance Q2FY23 (` mio) Q2 Diagnostics Clinics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 1,499 291 53 104 109 8 15 11 AHLL reported a revenue drop Footfalls/Day* 13,043 3,361 481 226 1,625 45 28 91 in Q2 FY23 on YoY basis due Gross ARPP (Rs.)* 776 1,548 3,317 5,287 1,6
Slide 17: Financial Performance H1 FY23
Financial Performance H1 FY23 (` mio) H1 Diagnostics Clinics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 1,499 291 53 104 109 8 15 11 Footfalls/Day* 11,631 3,537 480 212 1,562 44 28 92 AHLL reported a revenue drop in H1 Gross ARPP (Rs.)* 774 1,363 3,274 5,498 1,610 100,737 39,302 99,
Slide 18: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn)1 EBITDA* (INR Mn)2 Operational footprint (as of Sep 30, 2022) 1,087 1,040 914 922 18% 816 118 ~200 413 14% 306 358 99 12% Cities presence 11% in India 922 162 152 717 129 608 564 675 99 3% 22 97 Labs Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q2 FY22*
Slide 19: Digital Health & Pharmacy Distribution
Digital Health & Pharmacy Distribution Apollo Health Co 18
Slide 20: India's Largest Omni-Channel Healthcare
India’s Largest Omni-Channel Healthcare Apollo 247 –Digital Platform Apollo Pharmacy Platform Added As at September 30, 2022 527 H1 23 ~20Mn+ ~10.6 Lakh+ ~6,651+ Closed 54 Registrations Daily Active Users Doctors H1 23 Video and hospital consultations Chandigarh: 6 Net 473 Himachal Pradesh: 2 with d
Slide 21: Health Co Financials Q2 FY23
Health Co Financials Q2 FY23 Online ` Mio Offline Pharmacy Pharmacy Total Health o Q2 delivered GMV : ~Rs 294 cr (36% higher from Q1’22) Distribution Distribution & Co Apollo 247 o Sep run rate of ~50K/day transactions across Pharma, Total Revenues 15,101 1,582 16,683 Diagnostics and Consultations c
Slide 22: Health Co Financials H1 FY23
Health Co Financials H1 FY23 Online o H1 delivered GMV : ~Rs 510 cr (190% higher from H1 22) Offline Pharmacy Pharmacy Total Health ` Mio Distribution Distribution & Co Apollo 247 o Combined Pharmacy platform business reported revenue of Total Revenues 28,687 2,787 31,475 Rs 3,858 cr in H1 FY23 comp
Slide 23: Annexure
Annexure 22
Slide 24: Basis of Consolidation
Basis of Consolidation AHEL Standalone Location Description AHEL Ownership AHEL Subsidiaries Location Description Ownership Chennai Main Chennai Hospital Material Subs ACI - Chennai Chennai Hospital Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarpet - Chennai
Slide 25: IND AS 116: Impact on P&L and Balance Sheet H1FY23
` Mio IND AS - 116 : Impact on P&L and Balance Sheet – H1FY23 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 5,177 Revenue Right of use 10,639 Revenue - Asset Asset as of Other 407 as of Other 943 30th Sep, 2
Slide 26: Thank you!
SS Wi Thank you!
Apollo Hospitals Enterprise — Q2 FY23 Earnings Presentation on 6ix